Recruiting

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(14 sites)

United States

University of Alabama - Birmingham, Birmingham, Alabama

Regents of the University of California San Francisco, San Francisco, California

Northwestern University, Chicago, Illinois

Columbia University, New York, New York

University of North Carolina - Chapel Hill, Chapel Hill, North Carolina

Duke University, Durham, North Carolina

Case Western Reserve University, Cleveland, Ohio

Ohio State University, Columbus, Ohio

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania

Brown University, Providence, Rhode Island

Baylor College of Medicine, Houston, Texas

University of Texas - Houston, Houston, Texas

University of Utah Medical Center, Salt Lake City, Utah